Researchers at King’s College London have identified a novel potential in a commonly used drug for treating type 2 diabetes. They found that Metformin could serve as an effective means of preventing both oral and systemic diseases.
The study, conducted by researchers from the Faculty of Dentistry, Oral & Craniofacial Sciences, revealed that Metformin has the capability to regulate inflammation and sugar levels in the oral cavity, thereby offering protection against gum disease. Furthermore, it may play a role in guarding against diabetes and obesity.
According to King’s College London, the researchers observed that Metformin resulted in a significant reduction in bone loss, both during experimentally induced periodontal disease and age-related bone loss in living mice.
Metformin is widely accessible and cost-effective on a global scale, making it a potential avenue for improving the oral and overall health of many individuals.
Read Article:
Study Finds Diabetes Drug Could Prevent Gum Disease